ArticleBlood advances2018
Imatinib is still recommended for frontline therapy for CML.
Andrew Hantel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleBlood advances2018
Andrew Hantel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.